SENATE DOCKET, NO. 2665 FILED ON: 6/24/2021
SENATE . . . . . . . . . . . . . . No. 2492
|
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
John F. Keenan
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to collaborative drug therapy management optimization.
_______________
PETITION OF:
Name: | District/Address: |
John F. Keenan | Norfolk and Plymouth |
SENATE DOCKET, NO. 2665 FILED ON: 6/24/2021
SENATE . . . . . . . . . . . . . . No. 2492
By Mr. Keenan, a petition (accompanied by bill, Senate, No. 2492) (subject to Joint Rule 12) of John F. Keenan for legislation relative to collaborative drug therapy management optimization. Public Health. |
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Second General Court
(2021-2022)
_______________
An Act relative to collaborative drug therapy management optimization.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority of the same, as follows:
Notwithstanding section 24 B1/2 of chapter 112 of the General Laws or any other general or special laws to the contrary, collaborative drug therapy management may be allowed in ambulatory care clinics licensed pursuant to section 51 of chapter 111 of the General Laws if: (i) there is on-site or off-site supervision by the attending physician and a collaborating pharmacist; and (ii) collaborative drug therapy management is approved by the ambulatory care clinic's medical staff executive committee or designee or medical director or designee.